ROR2
Tyrosine-protein kinase transmembrane receptor ROR2
Also known as: BDB, BDB1, NTRKR2, ROR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01974
- Gene
- ROR2
- Ensembl
- ENSG00000169071
- Chromosome
- 9
- Canonical length
- 943 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
943 residues, UniProt reviewed canonical sequence.
>Q01974|ROR2
1 MARGSALPRR PLLCIPAVWA AAALLLSVSR TSGEVEVLDP NDPLGPLDGQ DGPIPTLKGY
61 FLNFLEPVNN ITIVQGQTAI LHCKVAGNPP PNVRWLKNDA PVVQEPRRII IRKTEYGSRL
121 RIQDLDTTDT GYYQCVATNG MKTITATGVL FVRLGPTHSP NHNFQDDYHE DGFCQPYRGI
181 ACARFIGNRT IYVDSLQMQG EIENRITAAF TMIGTSTHLS DQCSQFAIPS FCHFVFPLCD
241 ARSRTPKPRE LCRDECEVLE SDLCRQEYTI ARSNPLILMR LQLPKCEALP MPESPDAANC
301 MRIGIPAERL GRYHQCYNGS GMDYRGTAST TKSGHQCQPW ALQHPHSHHL SSTDFPELGG
361 GHAYCRNPGG QMEGPWCFTQ NKNVRMELCD VPSCSPRDSS KMGILYILVP SIAIPLVIAC
421 LFFLVCMCRN KQKASASTPQ RRQLMASPSQ DMEMPLINQH KQAKLKEISL SAVRFMEELG
481 EDRFGKVYKG HLFGPAPGEQ TQAVAIKTLK DKAEGPLREE FRHEAMLRAR LQHPNVVCLL
541 GVVTKDQPLS MIFSYCSHGD LHEFLVMRSP HSDVGSTDDD RTVKSALEPP DFVHLVAQIA
601 AGMEYLSSHH VVHKDLATRN VLVYDKLNVK ISDLGLFREV YAADYYKLLG NSLLPIRWMA
661 PEAIMYGKFS IDSDIWSYGV VLWEVFSYGL QPYCGYSNQD VVEMIRNRQV LPCPDDCPAW
721 VYALMIECWN EFPSRRPRFK DIHSRLRAWG NLSNYNSSAQ TSGASNTTQT SSLSTSPVSN
781 VSNARYVGPK QKAPPFPQPQ FIPMKGQIRP MVPPPQLYVP VNGYQPVPAY GAYLPNFYPV
841 QIPMQMAPQQ VPPQMVPKPS SHHSGSGSTS TGYVTTAPSN TSMADRAALL SEGADDTQNA
901 PEDGAQSTVQ EAEEEEEGSV PETELLGDCD TLQVDEAQVQ LEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ROR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- colon: 30 nTPM
- choroid plexus: 24 nTPM
- endometrium: 22 nTPM
- cervix: 17 nTPM
- urinary bladder: 17 nTPM
- parathyroid gland: 16 nTPM
Single-cell type
- choroid plexus epithelial cells: 1,201 nCPM
- mesothelial cells: 472 nCPM
- epicardial cells: 400 nCPM
- decidual stromal cells: 301 nCPM
- endometrial stromal cells: 292 nCPM
- smooth muscle cells: 253 nCPM
Immune cell
- MAIT T-cell: 1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 58 nTPM
- midbrain: 4.4 nTPM
- medulla oblongata: 3.6 nTPM
- hippocampal formation: 2.9 nTPM
- hypothalamus: 2.4 nTPM
- spinal cord: 2.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ROR2.
Disease | AllUniProt
Conditions ROR2 is implicated in, by any mechanism.
- Brachydactyly B1 (BDB1) MIM:113000
- Robinow syndrome, autosomal recessive 1 (RRS1) MIM:268310
Disease | GeneticClinVar
65 pathogenic / likely-pathogenic of 917 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive Robinow syndrome
- Brachydactyly type B1
- Robinow syndrome, autosomal recessive, with aplasia/hypoplasia of phalanges and metacarpals/metatarsals
- Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.14
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- positive regulation of cell migration
- signal transduction
- Wnt signaling pathway
Molecular functions
- ATP binding
- coreceptor activity
- metal ion binding
- mitogen-activated protein kinase kinase kinase binding
- transmembrane receptor protein tyrosine kinase activity
- Wnt-protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Kringle
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Kringle-like fold
- Tyrosine-protein kinase, receptor ROR
- Kringle, conserved site
- Frizzled domain
- Immunoglobulin-like domain superfamily
- Frizzled cysteine-rich domain superfamily
- Kringle superfamily
- Receptor Tyrosine Kinase
- Kringle domain
- Fz domain
- Immunoglobulin I-set domain
- Protein tyrosine and serine/threonine kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ROR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ROR2 as an antibody target. Whether an autoantibody or antibody against ROR2 could matter depends on whether native ROR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ROR2 is annotated at the cell surface, where native ROR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ROR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...